The Promise of Gene Therapy - Top-Institutions - MDSpire

The Promise of Gene Therapy

With phase 3 topline data for sura-vec expected later this year, Arshad M. Khanani, MD, FASRS, reflects on how gene therapy could transform long-term treatment for nAMD.

  • By

  • Arshad M. Khanani, MD, MA, FASRS

  • July 15, 2026

  • 2 min

Share

Top Institutions in Ophthalmology

Brief introduction explaining scope and methodology.

  • #1

    Children’s Hospital of Philadelphia
    Children’s Hospital of Philadelphia

    Philadelphia, Pennsylvania

    Key Differentiators

    • Gene Therapy
    • Pediatrics

  • #2

    Nationwide Children’s Hospital
    Nationwide Children’s Hospital

    Columbus, Ohio

    Key Differentiators

    • Gene Therapy
    • Pediatrics

  • #3

    American Academy of Ophthalmology
    American Academy of Ophthalmology

    San Francisco, California

    Key Differentiators

    • Ophthalmology
    • Genetics

  • #4

    American College of Medical Genetics and Genomics
    American College of Medical Genetics and Genomics

    Bethesda, Maryland

    Key Differentiators

    • Genetics
    • Medical Genetics

  • #5

    Scheie Eye Institute
    Scheie Eye Institute

    Philadelphia, Pennsylvania

    Key Differentiators

    • Ophthalmology
    • Genetics

Original Source(s)

The Promise of Gene Therapy

  • by Arshad M. Khanani, MD, MA, FASRS

  • July 15, 2026

Related Content

Epidemiology of retinopathy of prematurity (ROP) in Northwest China: a decade-long retrospective single-center analysis (2015–2024)

Myopia Patterns in Intermittent Exotropia

New findings indicate intermittent exotropia may influence binocular ocular growth patterns without significantly increasing myopia risk

  • July 15, 2026

  • 2 min
Early retinal volume changes after switching to brolucizumab in refractory neovascular age-related macular degeneration